Huntington's disease: present treatments and future therapeutic modalities

scientific article

Huntington's disease: present treatments and future therapeutic modalities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00004850-200403000-00001
P698PubMed publication ID15076012

P50authorGregor WenningQ1545203
P2093author name stringRaphael M Bonelli
Hans P Kapfhammer
P433issue2
P921main subjectHuntington's diseaseQ190564
P304page(s)51-62
P577publication date2004-03-01
P13046publication type of scholarly workreview articleQ7318358
P1433published inInternational Clinical PsychopharmacologyQ15751307
P1476titleHuntington's disease: present treatments and future therapeutic modalities
P478volume19

Reverse relations

cites work (P2860)
Q52721984A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward
Q45301537A grand challenge: providing benefits of clinical genetics to those in need.
Q36719669A systematic review of the treatment studies in Huntington's disease since 1990.
Q22255485Adherence to Use of a Home-Based Exercise DVD in People With Huntington Disease: Participants' Perspectives
Q35106341Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year
Q30389974Development of the Music Therapy Assessment Tool for Advanced Huntington's Disease: A Pilot Validation Study
Q28538703Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort
Q34657923Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease
Q24812417Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
Q45302209Huntington's disease with severe neck infection.
Q48899820Nucleus lentiformis – A new model for psychiatry?
Q45305500Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity
Q47106198Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury
Q35135966Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers
Q36510210Seminar on choreas
Q34330172Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease
Q24239973Therapeutic interventions for disease progression in Huntington's disease
Q24245948Therapeutic interventions for disease progression in Huntington's disease
Q24245803Therapeutic interventions for symptomatic treatment in Huntington's disease
Q34565872Treatment of children and adolescents with tics and Tourette syndrome
Q33874611Vascular chorea in adults and children

Search more.